ICON plc/ICLR

$306.00

-2.04%
-
1D1W1MYTD1YMAX

About ICON plc

ICON Public Limited Company is a healthcare intelligence and clinical research organization. The Company is engaged in providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organizations. It offers a range of specialized services to assist pharmaceutical, biotechnology and medical device companies to bring new drugs and devices to market faster. The Company's services include clinical research services, commercial positioning, consulting, early phase, strategic solutions, laboratories, language services, medical imaging, real world intelligence, site and patient solutions, COVID-19 clinical operation and decentralized and hybrid clinical solutions. It also provides its full range of clinical, consulting and commercial services across several sectors, which include biosimilars, biotechnology, government and public health solutions, medical devices and pharmaceuticals.

Ticker

ICLR

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Stephen Cutler

Employees

41,100

Headquarters

Dublin, Ireland

ICON plc Metrics

BasicAdvanced
$25.24B
Market cap
41.34
P/E ratio
$7.40
EPS
1.17
Beta
-
Dividend rate
$25.24B
1.16748
$344.77
$181.92
526.43K
1.207
39.666
40.858
27.07
3.15%
3.59%
6.9%
4.28%
41.341
3.109
2.732
24.74
4.89%
20.8%
42.65%
5.88%

What the Analysts think about ICON plc

Analyst Ratings

Majority rating from 16 analysts.
Buy

Price Targets

Average projection from 13 analysts.
15.16% upside
High $385.00
Low $285.00
$306.00
Current price
$352.38
Average price target

ICON plc Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
10.47% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$2.07B
0.55%
Net income
$216.4M
32.27%
Profit margin
10.47%
31.53%

ICON plc Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 0.54%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
$2.90
$3.11
$3.30
$3.46
-
Expected
$2.88
$3.08
$3.28
$3.44
$3.44
Surprise
0.86%
1.11%
0.64%
0.54%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for ICON plc stock?

ICON plc (ICLR) has a market cap of $25.24B as of April 15, 2024.

What is the P/E ratio for ICON plc stock?

The price to earnings (P/E) ratio for ICON plc (ICLR) stock is 41.34 as of April 15, 2024.

Does ICON plc stock pay dividends?

No, ICON plc (ICLR) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next ICON plc dividend payment date?

ICON plc (ICLR) stock does not pay dividends to its shareholders.

What is the beta indicator for ICON plc?

ICON plc (ICLR) has a beta rating of 1.17. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the ICON plc stock price target?

The target price for ICON plc (ICLR) stock is $352.38, which is 15.16% above the current price of $306. This is an average based on projections from 13 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell ICON plc stock

Buy or sell ICON plc stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing